RE:RE:ProMIS Neurosciences faces Nasdaq delisting riskHere it is.
https://www.investing.com/news/company-news/promis-neurosciences-regains-nasdaq-compliance-93CH-3542094
"
ProMIS Neurosciences Inc., a pharmaceutical company, announced today that it has regained compliance with the NASDAQ's minimum value requirement for continued listing on the NASDAQ Capital Market. This development follows a period of non-compliance with the NASDAQ Listing Rule 5550(b)(2), which necessitates a minimum market value of listed securities of $35 million. The notification of compliance was received by ProMIS Neurosciences on Monday, July 22, 2024, as indicated by the company's recent 8-K filing with the U.S. Securities and Exchange Commission. The compliance was achieved after the company's common shares maintained a closing market value of $35 million or greater for at least 10 consecutive business days, from July 8, 2024, to July 19, 2024.
The company's interim Chief Executive Officer, Neil Warma, signed the SEC filing, marking the official confirmation of the regained status. The NASDAQ Capital Market is a key platform for companies like ProMIS Neurosciences, providing access to a broad set of investors and the potential for increased liquidity.
This announcement marks the end of the compliance issue, with the NASDAQ Stock Market Listing Qualifications Staff considering the matter closed. ProMIS Neurosciences, headquartered in Toronto, Canada, is listed under the ticker symbol NASDAQ:PMN and is classified within the pharmaceutical preparations industry."